Elevated serum human growth hormone and decreased serum insulin in prediabetic males after intravenous tolbutamide and glucose
G. Boden, … , R. E. Gleason, A. Marble
G. Boden, … , R. E. Gleason, A. Marble
Published April 1, 1968
Citation Information: J Clin Invest. 1968;47(4):729-739. https://doi.org/10.1172/JCI105768.
View: Text | PDF
Research Article

Elevated serum human growth hormone and decreased serum insulin in prediabetic males after intravenous tolbutamide and glucose

Abstract

Serum human growth hormone (HGH), serum immunoreactive insulin (IRI), plasma free fatty acids, and blood glucose were measured during intravenous glucose and intravenous tolbutamide tolerance tests in 13 normal and 13 prediabetic (offspring of two diabetic parents) males, closely matched for weight and age. Only prediabetics with normal glucose tolerance during oral, intravenous, and cortisone-primed glucose tolerance tests were evaluated.

Authors

G. Boden, J. S. Soeldner, R. E. Gleason, A. Marble

×

Full Text PDF | Download (1.20 MB)